276 research outputs found
Role of preoperative magnetic resonance imaging and histological assessment in identifying patients with a low risk of endometrial cancer: a Korean Gynecologic Oncology Group ancillary study
Preoperative identification of individuals at low risk of lymph node metastasis is key to the proper management of endometrial cancer. This study evaluated the role of preoperative assessment based on magnetic resonance imaging (MRI) and histological analysis in identifying a group having a low risk of lymph node metastasis. Data of 529 patients with endometrial cancer were obtained from a prospective multicenter database, between January 2012 and December 2014. Clinical staging, based on MRI and histological analysis, was compared with final pathology results after the surgical staging procedure. The preoperative low-risk criteria, based on current guidelines from Korea, France, and Canada, and criteria used for fertility-sparing therapies, were applied to our multicenter cohort and the accuracy of each set of criteria for identifying group at low risk of lymph node metastasis was evaluated. When considering grades or MR stages separately, the overall agreement between preoperative and postoperative findings was poor (Kappa 0.45 for grades; 0.41 for stages). However, when combining these two parameters, the low-risk group, as defined by any of the guidelines, had an acceptable rate of lymph node metastasis (below 3%). The French guidelines identified 249 patients (47.1%) as being in the low-risk group. Criteria used to define fertility-sparing therapy candidates identified 48 patients (9.1%) among the study population, only one of whom had extra-uterine disease. This study shows that the current guidelines, using preoperative assessment based on MRI and histological analysis, can identify low-risk patients, who may be candidates for omitting lymphadenectomy.ope
Comparative Effectiveness of Abdominal versus Laparoscopic Radical Hysterectomy for Cervical Cancer in the Postdissemination Era
PURPOSE:
Despite the benefits of minimally invasive surgery for cervical cancer, there are a lack of randomized trials comparing laparoscopic radical hysterectomy and abdominal radical hysterectomy. We compared morbidity, cost of care, and survival between abdominal radical hysterectomy and laparoscopic radical hysterectomy for cervical cancer.
Materials and Methods:
We used the Korean nationwide database to identify women with cervical cancer who underwent radical hysterectomy from January 1, 2011 to December 31, 2014. Patients who underwent abdominal radical hysterectomy were compared to those who underwent laparoscopic radical hysterectomy. Perioperative morbidity, the use of adjuvant therapy, and survival were evaluated after propensity score balancing.
RESULTS:
We identified 6,335 patients, including 3,235 who underwent abdominal radical hysterectomy and 3,100 who underwent laparoscopic radical hysterectomy. The use of laparoscopic radical hysterectomy increased from 46.1% in 2011 to 51.8% in 2014. Patients who were younger, had a more recent year of diagnosis, and were treated in the metropolitan area were more likely to undergo a laparoscopic procedure (p < 0.001). Compared to abdominal radical hysterectomy, laparoscopic radical hysterectomy was associated with lower rates of complication, fewertransfusions, a shorter hospital stay, less adjuvant therapy, and reduced total medical costs (p < 0.001). Laparoscopic surgery was associated with a better overall survival than abdominal operation (hazard ratio, 0.74; 95% confidence interval, 0.64 to 0.85).
CONCLUSION:
In the postdissemination era, laparoscopic radical hysterectomy was associated with more favorable morbidity profiles, a lower cost of care, and comparable survival than abdominal radical hysterectomy.ope
The institutional learning curve is associated with survival outcomes of robotic radical hysterectomy for early-stage cervical cancer-a retrospective study
BACKGROUND:
Despite recent advances in diagnosis and treatment, cervical cancer continues to be a significant health problem worldwide. Whereas robot-assisted surgery has advantages over the abdominal approach, and minimally invasive techniques are being used increasingly, these may be associated with a higher recurrence rate and lower overall survival than the abdominal approach. The objective of this study was to compare the surgical and survival outcomes between abdominal radical hysterectomy (ARH) and robotic radical hysterectomy (RRH).
METHODS:
A retrospective cohort of patients undergoing radical hysterectomy for cervical cancer from 2006 to 2018 was identified. Patients with stage IA to IB cervical cancer were included and grouped: ARH vs. RRH. The RRH group was further divided into two groups based on the year of enrollment: RRH1 (2006-2012) and RRH2 (2013-2018). Tumor characteristics, recurrence rate, progression-free survival (PFS), and overall survival (OS) were compared between the groups. P-values <β0.05 (two-sided) were considered statistically significant.
RESULTS:
A total of 310 patients were identified: 142 and 168 underwent ARH and RRH, respectively. RRH1 and RRH2 had 77 and 91 patients, respectively. Interestingly, RRH2 was more likely to have a larger tumor size (1.7βΒ±β1.4 vs. 2.0βΒ±β1.1 vs. 2.4βΒ±β1.7βcm, Pβ=β0.014) and higher stage (Pβ<β0.001) than RRH1. However, RRH2 showed significantly favorable PFS in contrast to RRH1. There was no difference between ARH and RRH2 in PFS (Pβ=β0.629), whereas overall, the RRH group showed significantly shorter PFS than the ARH group. In the multivariate analysis, the institutional learning curve represented by the operation year was one of the significant predictors for PFS (hazard ratio [HR] 0.065, Pβ=β0.0162), along with tumor size (HR 5.651, Pβ=β0.0241).
CONCLUSIONS:
The institutional learning curve, represented by the operation year, is one of the most significant factors associated with outcomes of RRH for early-stage cervical cancer.ope
Tumor evolution and intratumor heterogeneity of an epithelial ovarian cancer investigated using next-generation sequencing
BACKGROUND: The extent to which metastatic tumors further evolve by accumulating additional mutations is unclear and has yet to be addressed extensively using next-generation sequencing of high-grade serous ovarian cancer.
METHODS: Eleven spatially separated tumor samples from the primary tumor and associated metastatic sites and two normal samples were obtained from a Stage IIIC ovarian cancer patient during cytoreductive surgery prior to chemotherapy. Whole exome sequencing and copy number analysis were performed. Omental exomes were sequenced with a high depth of coverage to thoroughly explore the variants in metastatic lesions. Somatic mutations were further validated by ultra-deep targeted sequencing to sort out false positives and false negatives. Based on the somatic mutations and copy number variation profiles, a phylogenetic tree was generated to explore the evolutionary relationship among tumor samples.
RESULTS: Only 6% of the somatic mutations were present in every sample of a given case with TP53 as the only known mutant gene consistently present in all samples. Two non-spatial clusters of primary tumors (cluster P1 and P2), and a cluster of metastatic regions (cluster M) were identified. The patterns of mutations indicate that cluster P1 and P2 diverged in the early phase of tumorigenesis, and that metastatic cluster M originated from the common ancestral clone of cluster P1 with few somatic mutations and copy number variations.
CONCLUSIONS: Although a high level of intratumor heterogeneity was evident in high-grade serous ovarian cancer, our results suggest that transcoelomic metastasis arises with little accumulation of somatic mutations and copy number alterations in this patient.ope
Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer
BACKGROUND:
Poly (ADP-ribose) polymerase inhibitors targeting BRCA1/2 mutations are available for treating patients with high-grade serous ovarian cancer. These treatments may be more appropriately directed to patients who might respond if the tumor tissue is additionally tested by next-generation sequencing with a multi-gene panel and Sanger sequencing of a blood sample. In this study, we compared the results obtained using the next-generation sequencing multi-gene panel to a known germline BRCA1/2 mutational state determined by conventional Sanger sequencing to evaluate the landscape of somatic mutations in high-grade serous ovarian cancer tumors.
METHODS:
Cancer tissue from 98 patients with high-grade serous ovarian cancer who underwent Sanger sequencing for germline BRCA1/2 analysis were consecutively analyzed for somatic mutations using a next-generation sequencing 170-gene panel.
RESULTS:
Twenty-four patients (24.5%) showed overall BRCA1/2 mutations. Seven patients (7.1%) contained only somatic BRCA1/2 mutations with wild-type germline BRCA1/2, indicating acquired mutation of BRCA1/2. Three patients (3.1%) showed reversion of germline BRCA1 mutations. Among the 14 patients (14.3%) with both germline and somatic mutations in BRCA1/2, two patients showed different variations of BRCA1/2 mutations. The next-generation sequencing panel test for somatic mutation detected other pathogenic variations including RAD51D and ARID1A, which are possible targets of poly (ADP-ribose) polymerase inhibitors. Compared to conventional Sanger sequencing alone, next-generation sequencing-based tissue analysis increased the number of candidates for poly (ADP-ribose) polymerase inhibitor treatment from 17.3% (17/98) to 26.5% (26/98).
CONCLUSIONS:
Somatic mutation analysis by next-generation sequencing, in addition to germline BRCA1/2 mutation analysis, should become the standard of care for managing women with high-grade serous ovarian cancer to widen the indication of poly (ADP-ribose) polymerase inhibitors.ope
Identifying a low-risk group for parametrial involvement in microscopic Stage IB1 cervical cancer using criteria from ongoing studies and a new MRI criterion
BACKGROUND: There are currently three ongoing studies on less radical surgery in cervical cancer: ConCerv, GOG-278, and SHAPE. The aim of this study was to evaluate the performance of the criteria used in ongoing studies retrospectively and suggest a new, simplified criterion in microscopic Stage IB1 cervical cancer.
METHODS: A retrospective analysis was performed in 125 Stage IB1 cervical cancer patients who had no clinically visible lesions and were allotted based on microscopic findings after conization. All patients had magnetic resonance imaging (MRI) after conization and underwent type C2 radical hysterectomy. We suggested an MRI criterion for less radical surgery candidates as patients who had no demonstrable lesions on MRI. The rates of parametrial involvement (PMI) were estimated for patients that satisfied the inclusion criteria for ongoing studies and the MRI criterion.
RESULTS: The rate of pathologic PMI was 5.6% (7/125) in the study population. ConCerv and GOG-278 identified 11 (8.8%) and 14 (11.2%) patients, respectively, as less radical surgery candidates, and there were no false negative cases. SHAPE and MRI criteria identified 78 (62.4%) and 74 (59.2%) patients, respectively, as less radical surgery candidates; 67 patients were identified as less radical surgery candidates by both sets of criteria. Of these 67 patients, only one had pathologic PMI with tumor emboli.
CONCLUSIONS: This study suggests that the criteria used in three ongoing studies and a new, simplified criterion using MRI can identify candidates for less radical surgery with acceptable false negativity in microscopic Stage IB1 disease.ope
μμ κ°μμ μ μμ‘°μ κΈ°λ₯
νμλ
Όλ¬Έ (λ°μ¬)-- μμΈλνκ΅ λνμ : μ¬λ¦¬νκ³Ό, 2015. 2. λ―Όκ²½ν.λ³Έ μ°κ΅¬μμλ μμ
κ°μμΌλ‘ κΈ°λΆμ μ‘°μ νλ λ°©λ΅μ μΈ‘μ νλ λꡬλ₯Ό λ§λ ¨νκ³ μ΄λ₯Ό μ΄μ©νμ¬ μ²λ
κΈ° μ±μΈμ λμμΌλ‘ μμ
κ°μμ ν΅ν΄ κΈ°λΆμ μ‘°μ νλ λ°©λ΅ μ¬μ©μμ μ΄λ ν κ°μΈμ°¨κ° λνλλμ§ νμνμμΌλ©° μμ
μ΄ μ μμ λ³νμ λ―ΈμΉλ μν₯μ μ€λ¬Έ μ°κ΅¬μ μ€ν μ°κ΅¬λ₯Ό ν΅νμ¬ νμΈνμλ€.
μ°κ΅¬ 1μμλ Music in Mood Regulation Scale(Saarikallio, 2008)μ μ²λ
κΈ°μ νκ΅μΈμ λμμΌλ‘ νλΉννμ¬ μ²λμ ꡬ쑰λ₯Ό μ΄ν΄λ³΄μλ€. νκ΅ν μμ
μ¬μ© κΈ°λΆμ‘°μ μ²λ(K-MMR)λ 6κ°μ νμ μμΈμΌλ‘ μ΄λ£¨μ΄μ Έ μμΌλ©° κ° νμ λ°©λ΅μ μ΄λ¦μ ν볡, λΆμΆ, κ°λ ¬ν λλ, μ€λ½, μ£Όμμ ν, μλ‘μλ€. κ° μμΈμ μ λ’°λλ₯Ό κ²μ¦νκ³ μλ ΄νλΉλμ λ³λ³νλΉλλ₯Ό κ²μ¦ν¨μΌλ‘μ¨ K-MMRμ΄ μ λ’°λ‘κ³ νλΉν λꡬμμ νμΈνμλ€.
μ°κ΅¬ 2μμλ K-MMRμ μ΄μ©νμ¬ μμ
κ°μμ ν΅ν κΈ°λΆμ‘°μ λ°©λ΅μ μ¬μ©μμ κ°μΈμ κ²½νμ΄λ νΉμ§μ λ°λΌμ μ΄λ ν κ°μΈμ°¨κ° λνλλμ§ νμνμλ€. μμ
μ κΈ°λ₯μ μ΄λΌκ³ μκ°νλ μ¬λλ€μΌμλ‘ μμ
μ μ¬μ©νμ¬ κΈ°λΆμ μ‘°μ νλ κ²½ν₯μ 보μκ³ , μμ
μ μ¬μ©ν κΈ°λΆμ‘°μ λ°©λ΅μ μ μ κ°μ μ κ²½νκ³Ό μ μν μκ΄μ΄ μμλ€. λ¨μ±λ³΄λ€ μ¬μ±μ΄ λ μμ
μΌλ‘ κΈ°λΆμ μ‘°μ νλ λ°©λ΅μ μ¬μ©νμμΌλ©° μμ
μ κ΅μ‘λ°μ μ§λ¨μ΄ κ·Έλ μ§ μμ μ§λ¨λ³΄λ€ λ μμ
μΌλ‘ κΈ°λΆμ μ‘°μ νλ λ°©λ΅μ μ¬μ©νμλ€. μμ
μ μ¬μ©ν κΈ°λΆμ‘°μ λ°©λ΅μ μμΈ‘νλ μ±κ²©νΉμ§μ νμ λ°©λ΅λ³λ‘ μ°¨λ³μ μΌλ‘ λνλ¬μΌλ©°, μμ
κ°μμ ν΅ν κΈ°λΆμ‘°μ λ°©λ΅κ³Ό κ°μ₯ κΉμ μ°κ΄μ΄ μλ μ±κ²©νΉμ§μ μ°νΈμ±κ³Ό κ²½νμ λν κ°λ°©μ±μΈ κ²μΌλ‘ λνλ¬λ€.
μ°κ΅¬ 3μμλ κ²½ννλ μ μμ κ°μνλ μμ
μ μ’
λ₯μ λ°λΌ μ μμ κ°μ μ μ°¨μ΄κ° λνλλμ§ μμ보기 μν΄ μ€ν μ°κ΅¬λ₯Ό μ€μνμμΌλ©°, μ μ μΈ‘μ μ μ λ’°λλ₯Ό λμ΄κΈ° μνμ¬ μκΈ°λ³΄κ³ μ μμ¨μ κ²½κ³μ νλμ λ°μνλ μ¬μ λλ₯Ό λμμ μΈ‘μ νμλ€. λΆλ
Έμ μ¬νμ λ κ°μ§ μ μλ₯Ό μ λ°νκ³ μ μΎν μμ
κ³Ό νμ¨ν μμ
μ λ€λ €μ£Όμλλ°, μκΈ°λ³΄κ³ μμμλ μ λ°λ μ μμ κ΄κ³μμ΄ μ μΎν μμ
μ΄ μ μ κ°μ μ ν¨κ³Όμ μ΄μμ§λ§ μ¬λ°λ³μ΄λ λΆμκ²°κ³Ό λΆλ
Έλ₯Ό κ²½νν λλ μ μΎν μμ
μ΄, μ¬νμ κ²½νν λλ νμ¨ν μμ
μ΄ ν¨κ³Όμ μΌλ‘ λνλ μ λ°μ μμ μμ
μ’
λ₯μ μνΈμμ©ν¨κ³Όκ° λ°κ²¬λμλ€. μμ
μ΄ μ μλ³νμ λ―ΈμΉλ ν¨κ³Όμ μμ
μ λν μΉμμ±, κΈ°μ§μ μ μ κ²½ν₯μ±κ³Ό κ°μ λ³μΈμ μν₯μ μ£Όμ§ λͺ»νλ κ²μΌλ‘ λνλ¬λ€.λͺ© μ°¨
μ λ‘ 1
μ¬λ¦¬νμ κ΄μ μμμ μμ
κ³Ό μ μ μ°κ΅¬ 3
μ μμ‘°μ μλ¨μΌλ‘μμ μμ
8
μ°κ΅¬μ νμμ± λ° λͺ©μ 20
μ°κ΅¬1. νκ΅ν μμ
μ¬μ© κΈ°λΆμ‘°μ μ²λμ νλΉν 23
λ°©λ² 26
κ²°κ³Ό λ° λ
Όμ 30
μ°κ΅¬2. μμ
μ ν΅ν κΈ°λΆμ‘°μ λ°©λ΅ μ¬μ©μμμ
κ°μΈμ°¨ νμ 39
λ°©λ² 40
κ²°κ³Ό λ° λ
Όμ 43
μ°κ΅¬3. μμ
κ°μμ΄ μ μλ³νμ λ―ΈμΉλ ν¨κ³Όμ± νμΈ 55
λ°©λ² 58
κ²°κ³Ό λ° λ
Όμ 66
μ’
ν© λ
Όμ 75
μ°Έκ³ λ¬Έν 85
λΆλ‘ 105
Abstract 122Docto
μ±ν₯μ μ맀μΉ(PSM) λ° μ΄μ€μ°¨μ΄λΆμ(DID) λ°©λ²μ μ€μ¬μΌλ‘
νμλ
Όλ¬Έ(μμ¬) -- μμΈλνκ΅λνμ : νμ λνμ 곡기μ
μ μ±
νκ³Ό, 2022. 8. μ΄μμ.This study focused on the fact that many studies have been conducted on the effectiveness of sales and leaseback, but few studies have quantitatively analyzed the financial effects of sales and leaseback support for SMEs. Accordingly, the effect of supporting policy funds was analyzed by comparing the performance of companies supported by the sales and leaseback system operated by the Korea Asset Management Corporation(KAMCO). As previously known, in the case of policy finance support programs, there is a possibility that selection bias will occur in the process of reviewing and deciding whether or not to support it. Therefore, this study tried to minimize the problem of selection bias through the DID(difference-in-difference) after extracting the control group by performing PSM(propensity score matching).
According to the analysis results, among the four areas of stability, profitability, activity, and growth, it shows the meaningful effect in stability indicators. Among the stability index, the currant ratio and the loan to sales ratio improved. In the case of profitability index, currant income, operating profit, and the net income to sales ratio increased. Among the activity index, the sales to total assets ratio was improved and in relation to growth index, the current asset growth rate improved. The results of this study suggest useful implications for analyzing the effectiveness of sales and leaseback support for SMEs, and it is also expected that the results will contribute to the activation of research for the effectiveness of sales and leaseback in public sector.λ³Έ μ°κ΅¬μ λͺ©μ μ μΈμΌμ€λ¦¬μ€λ°±μ ν¨κ³Όμ±κ³Ό κ΄λ ¨νμ¬ κ·Έλμ μλ§μ μ°κ΅¬λ€μ΄ μ΄λ£¨μ΄μ Έ μμΌλ μ€μκΈ°μ
μ λμμΌλ‘ μΈμΌμ€λ¦¬μ€λ°± μ§μμ λ°λ₯Έ μ¬λ¬΄ν¨κ³Όλ₯Ό κ³λμ μΌλ‘ λΆμν μ°κ΅¬λ κ±°μ μλ€λ μ μ μ°©μνμ¬ νκ΅μμ°κ΄λ¦¬κ³΅μ¬(μΊ μ½)μμ μ΄μνκ³ μλ μΈμΌμ€λ¦¬μ€λ°± μ λλ₯Ό μ§μλ°μ κΈ°μ
κ³Ό λΉμ§μκΈ°μ
μ μ±κ³Όλ₯Ό λΉκ΅νμ¬ μ μ±
ν¨κ³Όλ₯Ό νμΈν΄λ³΄κ³ μ νμλ€. κΈ°μ‘΄μ μλ €μ§ λ°μ κ°μ΄ μ μ±
κΈμ΅ μ§μ νλ‘κ·Έλ¨μ κ²½μ°μλ μ§μμ¬λΆλ₯Ό κ²ν νμ¬ κ²°μ νλ κ³Όμ μμ μκΈ°μ νμ μν νΈμ μμκ° λ°μνκ² λ κ°λ₯μ±μ΄ λ§€μ° ν¬λ€. λ°λΌμ λ³Έ μ°κ΅¬μμλ μ΄λ¬ν μ ννΈμμ λ¬Έμ λ₯Ό μ΅μννκΈ° μν΄ μ±ν₯μ μ맀μΉ(Propensity Score Matching)μ μ€μνμ¬ λμ‘°κ΅°μ μΆμΆνμκ³ μ΄μ€μ°¨μ΄λΆμ(Difference-in-Difference)κ³Ό κ²°ν©ν λͺ¨νμ νμ©νμ¬ κ΄μ°°ν μ μλ νΉμ±κ³Ό κ΄μ°°μ΄ λΆκ°λ₯ν μ¬λ¬ νΉμ±λ€μ ν΅μ νκ³ μ λ
Έλ ₯νμλ€.
λ³Έ μ°κ΅¬λ₯Ό ν΅ν μ€μ¦λΆμ κ²°κ³Όμ λ°λ₯΄λ©΄ μμ μ±, μμ΅μ±, νλμ±, μ±μ₯μ± 4κ° λΆμΌ μ€μμ μμ μ± μ§νκ° κ°μ₯ λΆλͺ
ν ν¨κ³Όλ₯Ό 보μ΄κ³ μλ κ²μΌλ‘ λνλ¬λ€. μμ μ± μ§ν μ€ μ λλΉμ¨, μ°¨μ
κΈλ§€μΆμ‘λΉμ¨μ΄ κ°μ λμμΌλ©°, μμ΅μ± μ§νμ κ²½μ° λΉκΈ°μμ΄μ΅, μμ
μ΄μ΅, 맀μΆμ‘μμ΄μ΅μ¨μ΄ κ°μ λμμμ νμΈν μ μμλ€. νλμ± μ§νμ κ²½μ° μ΄μμ°νμ μ¨, μ±μ₯μ± μ§νμ κ²½μ° μ λμμ°μ¦κ°μ¨μ΄ κΈμ μ ν¨κ³Όλ₯Ό 보μ΄κ³ μμμ΄ νμΈλμλ€.
μ΄μμ κ²°κ³Όλ₯Ό μ’
ν©μ μΌλ‘ νλ¨ν΄λ³΄λ©΄ μΈμΌμ€λ¦¬μ€λ°±μ μ§μλ°μ κΈ°μ
μ 곡μ₯, 건물 λ±μ μμ°μ μ°μ 맀μκΆ μ‘°κ±΄μΌλ‘ 맀κ°ν΄μ μ°¨μ
κΈ νμ λ± μ λμ± λΆμ‘±μ μΌμ°¨μ μΌλ‘ ν΄μνκ³ μ΄μ λ°λ₯Έ μ°¨μ
κΈ κ°μλ‘ μ λλΉμ¨, μ λμμ°μ¦κ°μ¨, μ°¨μ
κΈλ§€μΆμ‘λΉμ© λ± μμ μ±κ³Ό μ§γκ°μ μ μΌλ‘ κ΄λ ¨λ μ§νκ° κ°μ λλ κ²μΌλ‘ 보μΈλ€. μ λμ± λ¬Έμ λ₯Ό ν΄κ²°ν κΈ°μ
μ μ΄μ μκΈμ νμ©νμ¬ κΈ°μ
μ μ§μμ μΈ μμ΅μ°½μΆμ μν νλμ μ¬κ°νμ¬ λΉκΈ°μμ΄μ΅, μμ
μ΄μ΅μ΄ μΌλΆ μ¦κ°ν¨μ λ°λΌ 맀μΆμ‘μμ΄μ΅μ¨, μ΄μμ°νμ μ¨ λ±μ μμ΅μ±, νλμ± μ§νκ° κ°μ λμλ€κ³ μ μΆν΄λ³Ό μ μλ€.
λ³Έ μ°κ΅¬μ λΆμκ²°κ³Όλ μ€μκΈ°μ
μΈμΌμ€λ¦¬μ€λ°± μ§μμ ν¨κ³Όμ± λΆμμ μ μ©ν μμ¬μ μ μ μνλ©°, μ°κ΅¬κ²°κ³Όκ° ν₯ν μΈμΌμ€λ¦¬μ€λ°± μ€μμ λ°λ₯Έ ν¨κ³Όμ±μ νμ
νλ μ°κ΅¬λΆμΌμ νμ±νμ κΈ°μ¬νκΈΈ κΈ°λνλ€.μ 1μ₯ μλ‘ 1
μ 1μ μ°κ΅¬μ λ°°κ²½ λ° λͺ©μ 1
μ 2μ μ°κ΅¬μ λ²μ λ° λ°©λ² 3
μ 2μ₯ μ€μκΈ°μ
ꡬ쑰쑰μ κ³Ό μΈμΌμ€λ¦¬μ€λ°± 5
μ 1μ μ€μκΈ°μ
νν© 5
μ 2μ ꡬ쑰쑰μ λμ μ€μκΈ°μ
νν© 7
μ 3μ μΈμΌμ€λ¦¬μ€λ°± νλ‘κ·Έλ¨ 10
1.μ λμ κ°μ 10
2.μΊ μ½μ μΈμΌμ€λ¦¬μ€λ°± νλ‘κ·Έλ¨ μ΄μ 11
μ 3μ₯ μ νμ°κ΅¬ κ²ν 14
μ 1μ μΈμΌμ€λ¦¬μ€λ°± κ΄λ ¨ μ νμ°κ΅¬ 14
μ 2μ μ€μκΈ°μ
μ μ±
μκΈ μ§μ κΈ°μ
μ μ¬λ¬΄μ ν¨κ³Όμ± μ°κ΅¬ 16
μ 3μ μ νμ°κ΅¬μμ μ°¨λ³μ± 18
μ 4μ₯ μ°κ΅¬μ μ€κ³ 20
μ 1μ μ°κ΅¬λ°©λ² λ° κ°μ€μ€μ 20
1.μ°κ΅¬λ°©λ² 20
2.κ°μ€μ μ€μ 21
μ 2μ λ³μμ μ€μ 23
1.λ
립λ³μ 23
2.μ’
μλ³μ 24
3.ν΅μ λ³μ 25
μ 3μ μλ£μ μμ§ λ° λΆμ λ°©λ² 26
1.μ±ν₯μ μ맀μΉ(PSM) 27
2.μ΄μ€μ°¨λΆλ²(DID) 31
μ 5μ₯ μ€μ¦λΆμ κ²°κ³Ό 34
μ 1μ κΈ°μ ν΅κ³ λΆμ 34
μ 2μ κ°μ€κ²μ¦ 36
1.μμ μ± μ§ν 36
2.μμ΅μ± μ§ν 40
3.νλμ± μ§ν 44
4.μ±μ₯μ± μ§ν 47
μ 3μ κ°μ€κ²μ¦κ²°κ³Ό μμ½ 50
μ 6μ₯ κ²°λ‘ 51
μ 1μ μ°κ΅¬κ²°κ³Ό μμ½ 51
μ 2μ μ°κ΅¬μ μμ¬μ 53
μ 3μ μ°κ΅¬μ νκ³ 54μ
Safety of fertility-sparing surgery in primary mucinous carcinoma of the ovary
PURPOSE: The aim of this study is to evaluate the safety of fertility-sparing surgery as the treatment for patients with primary mucinous epithelial ovarian cancer.
MATERIALS AND METHODS: A retrospective study of patients with mucinous ovarian cancer between 1991 and 2010 was performed. The demographics and survival outcomes were compared between patients who underwent fertility-sparing surgery and those who underwent radical surgery.
RESULTS: A total of 110 patients underwent primary surgery. At the time of surgery, tumors appeared to be grossly confined to the ovaries in 90 patients, and evidence of metastasis was definite in 20 patients. Of the 90 patients with tumors that appeared to be grossly confined to the ovaries at surgical exploration, 35 (38.9%) underwent fertility-sparing surgery. The Kaplan- Meier curve and the log rank test showed no difference in either recurrence-free survival (p=0.792) or disease-specific survival (p=0.706) between the two groups. Furthermore, there was no significant difference in recurrence-free survival (p=0.126) or disease-specific survival (p=0.377) between the two groups, even when the analysis was limited to women below the age of 40. In a multivariate Cox model, fertility-sparing surgery had no effect on either recurrence-free survival (recurrence hazard ratio [HR], 1.20; 95% confidence interval [CI], 0.25 to 5.71) or disease-specific survival (death HR, 0.88; 95% CI, 0.17 to 4.60).
CONCLUSION: Fertility-sparing surgery in primary mucinous cancer grossly confined to the ovaries may be a safe option and one not associated with an increase in recurrence or mortality.ope
An Alternative Triage Strategy Based on Preoperative MRI for Avoiding Trimodality Therapy in Stage IB Cervical Cancer.
PURPOSE: Adjuvant chemoradiation following primary surgery is frequently indicated in patients with stage IB cervical cancer. The aim of this study is to evaluate the role of a magnetic resonance imaging (MRI)-based strategy in avoiding trimodality therapy.
MATERIALS AND METHODS: We retrospectively reviewed all patients with stage IB cervical cancer treated initially with primary surgery at Seoul National University Hospital. We suggest an alternative triage strategy in which the primary treatment modality is determined based on preoperative MRI findings. Using this strategy, primary surgery is only indicated when there is no evidence of parametrial involvement (PMI) and lymph node metastasis (LNM) in the MRI results; when there is evidence of either or both of these factors, primary chemoradiation is selected. Assuming that this strategy is applied to our cohort, we evaluate how the rate of trimodality therapy is affected.
RESULTS: Of the 254 patients in our sample, 77 (30.3%) had at least one category 1 risk factor (PMI, LNM, positive resection margin) upon pathologic examination. If the MRI-based strategy had been applied to our cohort, 168 patients would have undergone primary surgery and 86 would have undergone primary chemoradiation. Only 25 patients (9.8%) would have required trimodality therapy based on an indication of at least one category 1 pathologic risk factor following radical hysterectomy.
CONCLUSION: The inclusion of MRI in the decision-making process for primary treatment modality could have reduced the number of patients requiring trimodality therapy based on the indication of a category 1 risk factor from 30.3% to 9.8% in our cohort.ope
- β¦